top
Search terms
Results 1 - 10 of 11 - ordered by :
Pages: 1 2
Ehjournal

Abstract Aims ASSENT 3 (Assessment of the Safety and Efficacy of a New Thrombolytic) demonstrated that the bolus fibrinolytic tenecteplase (TNK), combined with enoxaparin (ENOX) or abciximab (ABCX), ...

European Heart Journal, Armstrong, Paul W., Wagner, Galen, Goodman, Shaun G., Van de Werf, Frans, Granger, Christopher, Wallentin, Lars, Fu, Yuling

Date : 01/08/2003 Item size : 146465 bytes
Ehjournal

According to local practice, 4415 patients did not have an indication for unfractionated heparin (stratum 1) and 1021 did (stratum 2). With non-fibrin specific (NFS) thrombolytic agents, ...

European Heart Journal, Peters, Ron J.G., Joyner, Campbell, Bassand, Jean-Pierre, Afzal, Rizwan, Chrolavicius, Susan, Mehta, Shamir R., Oldgren, Jonas, Wallentin, Lars, Budaj, Andrzej, Fox, Keith A., ...

Date : 01/02/2008 Item size : 255255 bytes
Ehjournal

Aim Lipoprotein-associated phospholipase A2 (Lp-PLA2) has been suggested as an independent predictor of cardiovascular events in epidemiological studies. Methods and results Blood samples were ...

European Heart Journal, Oldgren, Jonas, James, Stefan K., Siegbahn, Agneta, Wallentin, Lars

Date : 01/03/2007 Item size : 244550 bytes
Ehjournal

Low molecular weight heparin (dalteparin) compared to unfractionated heparin as an adjunct to rt-PA (alteplase) for improvement of coronary artery patency in acute myocardial infarction—the ...

European Heart Journal, Wallentin, Lars, Bergstrand, Lott, Dellborg, Mikael, Fellenius, Carin, Granger, Christopher B, Lindahl, Bertil, Lins, Lars-Eric, Nilsson, Tage, Pehrsson, Kenneth, Siegbahn, ...

Date : 01/05/2003 Item size : 195235 bytes
Ehjournal

Abstract Aims ASSENT 3 (Assessment of the Safety and Efficacy of a New Thrombolytic) demonstrated that the bolus fibrinolytic tenecteplase (TNK), combined with enoxaparin (ENOX) or abciximab (ABCX), ...

European Heart Journal, Armstrong, Paul W., Wagner, Galen, Goodman, Shaun G., Van de Werf, Frans, Granger, Christopher, Wallentin, Lars, Fu, Yuling

Date : 01/08/2003 Item size : 146421 bytes
Ehjournal

Methods and results In 6066 STEMI patients enrolled in the Assessment of the Safety and Efficacy of a New Thrombolytic-3 (ASSENT-3) trial with complete electrocardiographic data, we assessed the ...

European Heart Journal, Chang, Wei-Ching, Kaul, Padma, Fu, Yuling, Westerhout, Cynthia M., Granger, Christopher B., Mahaffey, Kenneth W., Wallentin, Lars, Van de Werf, Frans, Armstrong, Paul W.

Date : 01/02/2006 Item size : 180042 bytes
Ehjournal

According to local practice, 4415 patients did not have an indication for unfractionated heparin (stratum 1) and 1021 did (stratum 2). With non-fibrin specific (NFS) thrombolytic agents, ...

European Heart Journal, Peters, Ron J.G., Joyner, Campbell, Bassand, Jean-Pierre, Afzal, Rizwan, Chrolavicius, Susan, Mehta, Shamir R., Oldgren, Jonas, Wallentin, Lars, Budaj, Andrzej, Fox, Keith A., ...

Date : 01/02/2008 Item size : 246747 bytes
Ehjournal

Low molecular weight heparin (dalteparin) compared to unfractionated heparin as an adjunct to rt-PA (alteplase) for improvement of coronary artery patency in acute myocardial infarction—the ...

European Heart Journal, Wallentin, Lars, Bergstrand, Lott, Dellborg, Mikael, Fellenius, Carin, Granger, Christopher B, Lindahl, Bertil, Lins, Lars-Eric, Nilsson, Tage, Pehrsson, Kenneth, Siegbahn, ...

Date : 01/05/2003 Item size : 228852 bytes
Ehjournal

Abstract Aims ASSENT 3 (Assessment of the Safety and Efficacy of a New Thrombolytic) demonstrated that the bolus fibrinolytic tenecteplase (TNK), combined with enoxaparin (ENOX) or abciximab (ABCX), ...

European Heart Journal, Armstrong, Paul W., Wagner, Galen, Goodman, Shaun G., Van de Werf, Frans, Granger, Christopher, Wallentin, Lars, Fu, Yuling

Date : 01/08/2003 Item size : 183515 bytes
Ehjournal

Abstract Aim Lipoprotein-associated phospholipase A2 (Lp-PLA2) has been suggested as an independent predictor of cardiovascular events in epidemiological studies. Methods and results Blood samples ...

European Heart Journal, Oldgren, Jonas, James, Stefan K., Siegbahn, Agneta, Wallentin, Lars

Date : 01/03/2007